NCT07291219 Registry of Pavia Chronic Heart Failure Patients-observational Study
| NCT ID | NCT07291219 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 101 participants |
| Start Date | 2022-11-22 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 101 participants in total. It began in 2022-11-22 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Registry of Pavia chronic heart failure patients-observational study
Eligibility Criteria
Inclusion Criteria: * Give written informed consent to participate for the prospective evaluations * Suffer from CHF * Be aged 18 years and over Exclusion Criteria: * Withdrawn of the consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07291219 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07291219 currently recruiting?
Yes, NCT07291219 is actively recruiting participants. Contact the research team at S.Ghio@smatteo.pv.it for enrollment information.
Where is the NCT07291219 trial being conducted?
This trial is being conducted at Pavia, Italy.
Who is sponsoring the NCT07291219 clinical trial?
NCT07291219 is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. The trial plans to enroll 101 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.